Delayed Thromboxane or Tumor Necrosis Factor-α, But Not Leukotriene Inhibition, Attenuates Prolonged Pulmonary Hypertension in Endotoxemia
- 1 September 1995
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 310 (3) , 103-110
- https://doi.org/10.1097/00000441-199531030-00004
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- EFFECTS OF CHOLINERGIC BLOCKADE ON HEMODYNAMIC DISTURBANCES AND INTESTINAL LESIONS IN ENDOTOXIC SHOCK IN NEWBORN PIGLETSShock, 1994
- Vasodilator Action of Pentoxifylline on Microcirculation of Rat Cremaster MuscleAngiology, 1992
- Correlation of plasma cytokine elevations with mortality rate in children with sepsisThe Journal of Pediatrics, 1992
- A ten-year review of neonatal sepsis and comparison with the previous fifty-year experienceThe Pediatric Infectious Disease Journal, 1990
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- Effect of leukotriene inhibitor LY-171883 on the pulmonary response to Escherichia coli endotoxemiaCritical Care Medicine, 1990
- Thromboxane synthesis inhibition reverses group B Streptococcus—induced pulmonary hypertensionCritical Care Medicine, 1987
- Effect of the Thromboxane A2-Receptor Antagonists, SQ 29,548 and SQ 28,668, on the Pulmonary Hypertensive Response to Endotoxemia in SwinePharmacology, 1987
- Regulation of rat natural killingCellular Immunology, 1986
- A radiochemical assay for detection of leukotriene B4 production from isolated cellsJournal of Pharmacological Methods, 1984